|
Volume
21 Number 7
July 2019
|
|
Home
>
Publications
>
Neuro-Oncology
Reviews >
Volume
21, Year 2019 >
Number 7, July
|
|
|
|
Ranjan
S, Skorupan N, Ye X, Sivakumar A, Yankulina O, Kamson D, Grossman
SA, Dzaye O, Holdhoff M.
Patterns
of bevacizumab use in patients with glioblastoma: an online
survey
among experts in neuro-oncology.
Neurooncol
Pract.
2019 Jul 6. 2020;7(1):52-58. doi: 10.1093/nop/npz022. _
|
|
|
|
Osswald
M, Jung E, Wick W, Winkler F.
Tunneling
nanotube‐like structures in brain tumors.
Cancer
Rep
(Hoboken).
2019 Jul 11. 2019;2(6):e1181. doi: 10.1002/cnr2.1181.
Review.
_
|
|
|
Central
nervous system tumors
|
▲
|
|
Nauclér CS, Geisler J, Vetvik K.
The emerging role
of human cytomegalovirus infection in human carcinogenesis: a
review of current evidence and potential therapeutic implications.
Oncotarget.
2019 Jul 2. 2019;10(42):4333-4347. doi: 10.18632/oncotarget.27016.
_
|
|
|
|
Ostrom QT, Adel Fahmideh M, Cote DJ, Muskens IS, Schraw JM,
Scheurer ME, Bondy ML.
Risk Factors For Childhood And
Adult Primary Brain Tumors.
Neuro
Oncol. 2019 Jul 12. doi: 10.1093/neuonc/noz123.
_
|
|
|
Gliomas
|
▲
|
|
|
High-grade
gliomas
|
|
|
Hu YJ, Zhang LF, Ding C, Chen D, Chen J.
Hypofractionated
stereotactic radiotherapy combined with chemotherapy or not in the
management of recurrent malignant gliomas: A systematic review and
meta-analysis.
Clin
Neurol Neurosurg. 2019 Jun 25. 2019;183:105401.
doi: 10.1016/j.clineuro.2019.105401. _
|
|
|
|
Mormile R.
Aspirin Use and Risk of Glioma: a Double Track
for a Single Goal?
Pathol
Oncol Res. 2019 Jul 22. doi:
10.1007/s12253-019-00699-w. _
|
|
|
|
Straube C, Kessel KA, Zimmer C, Schmidt-Graf F, Schlegel J, Gempt
J, Meyer B, Combs SE.
A Second Course of Radiotherapy in
Patients with Recurrent Malignant Gliomas: Clinical Data on
Re-irradiation, Prognostic Factors, and Usefulness of Digital
Biomarkers.
Curr
Treat Options Oncol. 2019 Jul 19. 2019;20(9):71.
doi: 10.1007/s11864-019-0673-y. _
|
|
|
|
Youssef GC, Gomez-Manzano C, Sawaya R, Fueyo J.
Antitumor
immune response during glioma virotherapy.
Neuro
Oncol. 2019 Jul 26. doi: 10.1093/neuonc/noz114.
_
|
|
|
Diffuse
astrocytic and oligodendroglial tumors
|
▲
|
|
Cohen KJ et al, PDQ Pediatric Treatment Editorial Board.
Childhood Astrocytomas Treatment (PDQ®): Health
Professional Version.
PDQ
Cancer Inf Summ. 2019 Jun 24. NCBI
Bookshelf:
NBK65944.
_
|
|
|
|
Cohen
KJ et al, PDQ Pediatric Treatment Editorial Board.
Childhood
Brain Stem Glioma Treatment (PDQ®): Health Professional
Version.
PDQ
Cancer Inf Summ.
2019 Jun 19. NCBI
Bookshelf:
NBK65812.
_
|
|
|
|
Ritchey AK et al, PDQ
Pediatric Treatment Editorial Board.
Childhood
Astrocytomas Treatment (PDQ®): Patient Version.
PDQ
Cancer Inf Summ. 2019 Jul 3. NCBI
Bookshelf:
NBK65954. _
|
|
|
Glioblastoma
|
|
|
Bailly C, Vidal A, Bonnemaire C, Kraeber-Bodéré F,
Chérel M, Pallardy A, Rousseau C, Garcion E, Lacoeuille F,
Hindré F, Valable S, Bernaudin M, Bodet-Milin C, Bourgeois
M.
Potential for Nuclear Medicine Therapy for
Glioblastoma Treatment.
Front
Pharmacol. 2019 Jul 10. 2019;10:772. doi:
10.3389/fphar.2019.00772. _
|
|
|
|
Çetin A, Biltekin B.
Ellagic Acid Enhances
Antitumor Efficacy of Temozolomide in an in vitro Glioblastoma
Model.
Turk
Neurosurg. 2019 May 17. doi:
10.5137/1019-5149.JTN.26026-19.1. _
|
|
|
|
Desai K, Hubben A, Ahluwalia M.
The Role of Checkpoint
Inhibitors in Glioblastoma.
Target
Oncol. 2019 Jul 9. 2019;14(4):375-394. doi:
10.1007/s11523-019-00655-3. _
|
|
|
|
Fan X, Xiong Y, Wang Y.
A reignited debate over the
cell(s) of origin for glioblastoma and its clinical implications.
Front
Med. 2019 Jul 16. doi: 10.1007/s11684-019-0700-1.
_
|
|
|
|
Jackson CM, Choi J, Lim M.
Mechanisms of immunotherapy
resistance: lessons from glioblastoma.
Nat
Immunol. 2019 Jul 29. doi:
10.1038/s41590-019-0433-y. _
|
|
|
|
Sander C, Reuschel V, Eisenlöffel C, Nestler U, Meixensberger
J.
Familial glioblastoma clustering in adult patients: a
case report of two non-twin siblings and review of the literature.
Int
Med Case Rep J. 2019 Jul 5. 2019;12:205-211. doi:
10.2147/IMCRJ.S201488. _
|
|
|
|
Weller M, Le Rhun E, Preusser M, Tonn JC, Roth P.
How we
treat glioblastoma.
ESMO
Open. 2019 Jun 17. 2019;4(Suppl 2):e000520. doi:
10.1136/esmoopen-2019-000520. _
|
|
|
Diffuse
midline glioma
|
|
|
Gallitto M, Lazarev S, Wasserman I, Stafford JM, Wolden SL,
Terezakis SA, Bindra RS, Bakst RL.
Role of Radiation
Therapy in the Management of Diffuse Intrinsic Pontine Glioma: A
Systematic Review.
Adv
Radiat Oncol. 2019 Mar 30. 2019;4(3):520-531. doi:
10.1016/j.adro.2019.03.009. _
|
|
|
|
Vitanza NA, Monje M.
Diffuse Intrinsic Pontine Glioma:
From Diagnosis to Next-Generation Clinical Trials.
Curr
Treat Options Neurol. 2019 Jul 10. 2019;21(8):37.
doi: 10.1007/s11940-019-0577-y. _
|
|
|
bottom
|
▲
|
|
|
